Published date: 23 February 2018

Last edited date: 23 February 2018

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 14 March 2018

Contract summary

Industry

  • Medical equipments, pharmaceuticals and personal care products - 33000000

  • Pharmaceutical products - 33600000

  • Medicinal products for dermatology and the musculo-skeletal system - 33630000

Location of contract

SO16 7QF

Value of contract

£80,000 to £117,000

Procurement reference

17/MED/113

Published date

23 February 2018

Closing date

14 March 2018

Contract start date

1 April 2018

Contract end date

31 March 2023

Contract type

Supply contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

The University of Southampton is looking for a company to procure, re-package, label, store & distribute a drug to 5 health care sites across England.

The requirement is for use in a multicentre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of spironolactone in the treatment of moderate-severe persistent acne in adult women compared to placebo, in addition to standard treatment.

The two equal arms are as follows:

o Oral spironolactone 50 mg/100mg once daily for 24 weeks plus standard care
o Placebo once daily for 24 weeks plus standard care

More information

Links

Additional text

Is a Recurrent Procurement Type? : No

About the buyer

Contact name

Tony Fay

Address

Burgess Road
University of Southampton
Hampshire
SO16 7QF
United Kingdom

Telephone

+44 2380594696

Email

a.s.fay@soton.ac.uk